期刊文献+

大肠癌患者癌旁粘膜中生长抑素及其分泌细胞的变化和意义 被引量:9

Somatostatin and its secretory cells in tumor surrounding mucosa in colorectal cancer patients and its significance
原文传递
导出
摘要 作者对大肠癌患者癌旁粘膜中生长抑素(SS)水平进行了放射免疫测定(RIA),并对SS分泌细胞(SS细胞)进行了免疫细胞化学观察。结果表明,癌近旁粘膜(CAM,距肿瘤0cm~2cm)SS水平高于癌远旁粘膜(CDM,距肿瘤约5cm);无异型增生之CAM中SS水平高于有不同程度异型增生者,相差均非常显著(P<0.01)。CAM中,SS水平与异型增生程度间呈非常显著之负相关(P<0.01)。SS细胞的形态、位置近于正常;CAM中SS细胞数和总阳性强度均高于CDM粘膜,相差非常显著(P<0.01)。CAM中SS水平与SS细胞数和总阳性强度间均呈非常显著之正相关(P<0.01)。作者认为,CAM中SS上升的主要原因是粘膜中SS细胞数量增多并分泌大量的SS,这可能有助于延缓异型增生的加重和肿瘤的发生、发展,是机体发生于病灶局部的一种防御反应。 The somatostatin(SS) levels in tumor surrounding mucosae were determined by RIA, and the SS secretory cells in these tissues were observed by immunocytochemistry in colorectal cancer patients.The mean SS level was higher in cancer adjacent mucosa(CAM, 0 ̄2cm from the tumor) than in cancer distant mucosa(CDM, about 5cm from the tumor),and in CAM without atypical hyperplasia than in such mucosa with different grades of atypical hyperplasia( P <0 01). In CAMs, there was a very significant negative correlation between the SS level and cell dysplasia( P <0 01). The form and location of SS cells in all tumor surrounding mucosae were similar to the normal. Both the mean SS cell number and total positive degree were very significantly higher in CAM than CDM ( P <0 01). SS levels in CAMs were correlated positively with the SS cell numbers and the total positive degrees in CAM ( P <0 01).It is concluded that the elevation of SS level in CAM is mainly caused by the increase of SS cells, which secrete more SS. The change of SS in colorectal cancer surrounding mucosa may play an important role in inhibiting the development of CAM atypical hyperplasia or the tumor,and is a local defensive reaction in the body.
出处 《中华外科杂志》 CAS CSCD 北大核心 1997年第5期268-270,共3页 Chinese Journal of Surgery
关键词 大肠肿瘤 癌旁粘膜 生长抑素 分泌细胞 Colorectal neoplasms Mucous membrane Somatostatin
  • 相关文献

参考文献6

  • 1王元和,解放军医学杂志,1995年,20卷,48页
  • 2赵荣华,解放军医学情报,1994年,8卷,19页
  • 3赵荣华,国外医学.消化系疾病分册,1991年,11卷,160页
  • 4陈培辉,中华病理学杂志,1990年,19卷,86页
  • 5Wang C W,Cancer Lett,1988年,43卷,139页
  • 6Cheng H,Am J Anato,1974年,141卷,537页

同被引文献75

  • 1王艳颖,鄢风昌,李春梅.直肠癌ER/PE受体表达及预后关系的病理学分析[J].肿瘤防治研究,1996,23(1):30-31. 被引量:3
  • 2郭贵然,于世华,潘月珍,张玉敏.大肠癌雌激素受体与孕激素受体表达及临床病理学分析[J].肿瘤研究与临床,1997,9(1):7-9. 被引量:5
  • 3殷健,梁延杰,汪鸿志,李素琴.关于大肠癌内分泌细胞及其分泌激素意义的研究[J].中华肿瘤杂志,1997,19(3):192-195. 被引量:7
  • 4Kameda T,Yasui W,Tsujino T,et al. Tyrosine kinase activity of epidermal growth factor receptor in human gastric carcinoma [ J ]. Pathol Res Pract, 1992,188:37 - 39.
  • 5Schlegel J, Merdes A, Stumm G,et al. Amplification of the EGFR gene correlates with different growth behaviour in human glioblastoma[ J ]. Int J Cancer, 1994,56 ( 1 ) :72 - 77.
  • 6Xiangming C, Natsugoe S,Takao S, et al. The cooperative role of p27 with cyclin E in the prognosis of advanced gastric carcinoma [ J ]. Cancer,2000,89:1214- - 1219.
  • 7Yasui W, Hata T, Yokzaki H, et al. Interaction between epidermal growth factor and its receptor in progression of human gastric carcinoma[J]. Int J Cancer,1988,41:211 -217.
  • 8Pinski J, Halmos G, Yano T, et al. Inhibition of growth of MKN45 human gastric carcinoma xenografts in nude mice by treatment with bombesin/gastrin -releasingpeptide antagonist and somatostatin analogue RC - 160[ J]. Int J Cancer, 1994,57 (4) :574 - 580.
  • 9Kouroumalis E, Skordilis P,Thermos K, et al. Treatment of hepatocellular carcinoma with octreotide : a randomised controlled study [ J ]. Gut, 1998,42:442 - 447.
  • 10Parson SL, Watson SA, Collins, HM, et al. Gelatinase ( MMP - 2 and MMP - 9 ) expression in gastrointestinal malignancy [ J ]. Br J Cancer, 1998,78 : 1495-1502.

引证文献9

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部